Covered recipient · General Payments record
MAYA RANKOVA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$7,661.77
- Reported across 454 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $853.09 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $214.37 | 11 |
| EISAI INC. | $150.50 | 2 |
| Novo Nordisk AS | $93.37 | 4 |
| Amgen Inc. | $91.94 | 4 |
| Lilly USA, LLC | $74.99 | 3 |
| PFIZER INC. | $67.27 | 3 |
| Merck Sharp & Dohme Corporation | $44.62 | 2 |
| Lundbeck LLC | $40.57 | 2 |
| Azurity Pharmaceuticals, Inc. | $31.30 | 2 |
| Renalytix AI, Inc. | $23.01 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.37 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374577 | CMS |
| ABBVIE INC. | $13.31 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374581 | CMS |
| ABBVIE INC. | $19.42 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374585 | CMS |
| ABBVIE INC. | $26.87 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374589 | CMS |
| ABBVIE INC. | $5.54 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374593 | CMS |
| ABBVIE INC. | $21.79 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374597 | CMS |
| ABBVIE INC. | $28.79 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374602 | CMS |
| ABBVIE INC. | $16.94 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374606 | CMS |
| ABBVIE INC. | $33.61 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374610 | CMS |
| ABBVIE INC. | $1.71 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374614 | CMS |
| ABBVIE INC. | $27.02 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374618 | CMS |
| Amgen Inc. | $20.60 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117360748 | CMS |
| Amgen Inc. | $24.20 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117360750 | CMS |
| Amgen Inc. | $25.26 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116043664 | CMS |
| Amgen Inc. | $21.88 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117360752 | CMS |
| Azurity Pharmaceuticals, Inc. | $17.73 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134011473 | CMS |
| Azurity Pharmaceuticals, Inc. | $13.57 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134011475 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.15 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101362406 | CMS |
| Eisai Inc. | $125.00 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764801 | CMS |
| Eisai Inc. | $25.50 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764799 | CMS |
| Lilly USA, LLC | $21.53 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135202614 | CMS |
| Lilly USA, LLC | $28.15 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135186421 | CMS |
| Lilly USA, LLC | $25.31 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135202618 | CMS |
| Lundbeck LLC | $21.99 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145959570 | CMS |
| Lundbeck LLC | $18.58 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145959572 | CMS |
| Merck Sharp & Dohme LLC | $21.93 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141664378 | CMS |
| Merck Sharp & Dohme LLC | $22.69 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141859712 | CMS |
| Novo Nordisk Inc | $23.08 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097633108 | CMS |
| Novo Nordisk Inc | $24.49 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097735331 | CMS |
| Novo Nordisk Inc | $22.16 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097682760 | CMS |
| Novo Nordisk Inc | $23.64 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097459205 | CMS |
| PFIZER INC. | $20.68 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131572086 | CMS |
| PFIZER INC. | $21.73 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131665007 | CMS |
| PFIZER INC. | $24.86 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130989528 | CMS |
| Renalytix AI, Inc. | $23.01 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116759830 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.